|
|
Novavax Awarded Funding from CEPI for COVID-19 Vaccine Development |
Novavax announced that the Coalition for Epidemic Preparedness Innovations awarded an initial funding of $4 million to support Novavax’ efforts to develop... |
|
|
Albireo Completes Enrollment in Phase 2 Study of Elobixibat in NASH/NAFLD |
Albireo Pharma announced achievement of full patient enrollment in its Phase 2 clinical trial of elobixibat 5mg, a first-in-class, once daily, orally... |
|